Clinical Trials Directory

Trials / Conditions / Acid Sphingomyelinase Deficiency

Acid Sphingomyelinase Deficiency

7 registered clinical trials studyying Acid Sphingomyelinase Deficiency — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Th
NCT06192576
Sanofi—
RecruitingGammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Mo
NCT05992532
Fundación Española de Hematología y Hemoterapía—
CompletedPREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"
NCT05641103
Fundación Española de Hematología y Hemoterapía—
CompletedA Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sp
NCT06949358
SanofiPhase 2
CompletedA Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
NCT04845958
Sanofi—
Enrolling By InvitationScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
NCT05368038
Albert Einstein College of Medicine—
TerminatedSafety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick
NCT00410566
Genzyme, a Sanofi CompanyPhase 1